CA2934828A1 - Prostate cancer gene profiles and methods of using the same - Google Patents

Prostate cancer gene profiles and methods of using the same Download PDF

Info

Publication number
CA2934828A1
CA2934828A1 CA2934828A CA2934828A CA2934828A1 CA 2934828 A1 CA2934828 A1 CA 2934828A1 CA 2934828 A CA2934828 A CA 2934828A CA 2934828 A CA2934828 A CA 2934828A CA 2934828 A1 CA2934828 A1 CA 2934828A1
Authority
CA
Canada
Prior art keywords
genes
patient
prostate cancer
expression
probes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2934828A
Other languages
English (en)
French (fr)
Inventor
Shiv K. Srivastava
Albert Dobi
Gyorgy Petrovics
Thomas Werner
Martin Seifert
Matthias Scherf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENOMATIX
Henry M Jackson Foundation For Advancement Of Military Medici Inc
Original Assignee
GENOMATIX
Henry M Jackson Foundation For Advancement Of Military Medici Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GENOMATIX, Henry M Jackson Foundation For Advancement Of Military Medici Inc filed Critical GENOMATIX
Publication of CA2934828A1 publication Critical patent/CA2934828A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G01N33/57555—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Epoxy Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CA2934828A 2013-12-30 2014-12-29 Prostate cancer gene profiles and methods of using the same Abandoned CA2934828A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361921739P 2013-12-30 2013-12-30
US61/921,739 2013-12-30
PCT/US2014/072610 WO2015103166A1 (en) 2013-12-30 2014-12-29 Prostate cancer gene profiles and methods of using the same

Publications (1)

Publication Number Publication Date
CA2934828A1 true CA2934828A1 (en) 2015-07-09

Family

ID=53493959

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2934828A Abandoned CA2934828A1 (en) 2013-12-30 2014-12-29 Prostate cancer gene profiles and methods of using the same

Country Status (8)

Country Link
US (1) US20160326594A1 (enExample)
EP (1) EP3090265B1 (enExample)
JP (1) JP2017509351A (enExample)
CN (1) CN106796236A (enExample)
AU (1) AU2014373927B2 (enExample)
CA (1) CA2934828A1 (enExample)
WO (1) WO2015103166A1 (enExample)
ZA (1) ZA201604370B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3519B1 (ar) 2013-01-25 2020-07-05 Amgen Inc تركيبات أجسام مضادة لأجل cdh19 و cd3
WO2017127550A1 (en) * 2016-01-19 2017-07-27 Wayne State University Prostate cancer aggressiveness gene signatures for subjects of african or european descent
AU2018266632B2 (en) * 2017-05-12 2024-07-25 The Henry M. Jackson Foundation For The Advancement Of Military Medicine. Inc. Prostate cancer gene profiles and methods of using the same
WO2019169336A1 (en) * 2018-03-02 2019-09-06 The Johns Hopkins University Methods for prostate cancer detection
CN110054674B (zh) * 2019-03-07 2022-08-05 深圳市龙华区人民医院 免疫原性多肽以及抗ttc36抗体ap2-19及应用
CN110628908B (zh) * 2019-09-19 2022-05-10 北京恩泽康泰生物科技有限公司 用于前列腺癌诊断分级和良恶性预测的生物标志物及检测试剂盒
CN111893177B (zh) * 2020-08-19 2022-10-04 南通大学 遗传性耳聋诱导基因的突变筛选方法及突变检测试剂盒
CN113284559B (zh) * 2021-07-21 2021-10-15 暨南大学 一种物种基因组的启动子查询方法、系统及设备

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US20050032065A1 (en) * 2002-06-24 2005-02-10 Afar Daniel E. H. Methods of prognosis of prostate cancer
US20040191783A1 (en) * 2003-03-31 2004-09-30 Guy Leclercq Low density micro-array analysis in human breast cancer
CA2992180C (en) * 2004-05-07 2021-02-23 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer
US20100143247A1 (en) * 2004-11-24 2010-06-10 St. George's Enterprises Limited Diagnosis of prostate cancer
CN101310185A (zh) * 2005-09-19 2008-11-19 约翰·霍普金斯大学 前列腺癌的生物标记
US8338109B2 (en) * 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
US20080254481A1 (en) * 2006-11-13 2008-10-16 Invitrogen Corporation Methods and kits for detecting prostate cancer biomarkers
JP5781922B2 (ja) * 2008-04-10 2015-09-24 ザ ヘンリー エム．ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディスン，インコーポレーテッド Ｅｒｇ遺伝子発現における前立腺癌特異的変化ならびにそれらの変化に基づく検出および治療方法
EP2370813A4 (en) * 2008-12-04 2012-05-23 Univ California MATERIALS AND METHODS FOR DIAGNOSIS AND PRESENTATION OF PROSTATE CANCER
FR2945820A1 (fr) * 2009-05-25 2010-11-26 Univ Clermont Auvergne Panel de genes pour le pronostic du cancer de la prostate
CA2795776A1 (en) * 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers for disease
ES2925983T3 (es) * 2010-07-27 2022-10-20 Genomic Health Inc Método para usar la expresión génica para determinar el pronóstico del cáncer de próstata
EP2606353A4 (en) * 2010-08-18 2014-10-15 Caris Life Sciences Luxembourg Holdings CIRCULATING BIOMARKERS FOR DISEASES
WO2012031008A2 (en) * 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
EP2514836B1 (en) * 2011-04-19 2016-06-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Prostate cancer markers
CA2835728A1 (en) * 2011-05-12 2012-11-15 Noviogendix Research B.V. Molecular markers in prostate cancer
CA2844671A1 (en) * 2011-08-08 2013-02-14 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Biomarker compositions and methods
JP2014525584A (ja) * 2011-08-31 2014-09-29 オンコサイト コーポレーション 癌の治療および診断のための方法および組成物
SE536352C2 (sv) * 2011-10-24 2013-09-03 Chundsell Medicals Ab Markörgener för klassificiering av prostatacancer
AU2012331104B2 (en) * 2011-11-04 2018-03-15 Mdxhealth Research B.V. Combinations of molecular markers in prostate cancer providing a diagnostic tool with improved sensitivity/specificity
US9863002B2 (en) * 2012-06-04 2018-01-09 North Carolina Central University Genetic determinants of prostate cancer risk

Also Published As

Publication number Publication date
ZA201604370B (en) 2020-12-23
CN106796236A (zh) 2017-05-31
AU2014373927A1 (en) 2016-07-07
EP3090265A4 (en) 2018-03-21
JP2017509351A (ja) 2017-04-06
EP3090265A1 (en) 2016-11-09
WO2015103166A1 (en) 2015-07-09
US20160326594A1 (en) 2016-11-10
AU2014373927B2 (en) 2018-03-22
EP3090265B1 (en) 2020-04-08

Similar Documents

Publication Publication Date Title
EP3090265B1 (en) Prostate cancer gene profiles and methods of using the same
JP6285009B2 (ja) 前立腺ガンの予後の検知及び判定のための組成物及び該検知及び判定方法
US10711311B2 (en) Genomic rearrangements associated with prostate cancer and methods of using the same
US20250369053A1 (en) Recurrence gene signature across multiple cancer types
US20240218451A1 (en) Prostate cancer gene profiles and methods of using the same
US20150344962A1 (en) Methods for evaluating breast cancer prognosis
WO2010108638A9 (en) Tumour gene profile
US20220033913A1 (en) Genomic rearrangements associated with prostate cancer and methods of using the same
US10081842B2 (en) Prostate cancer gene expression profiles
WO2024178032A2 (en) Methods for diagnosing and treating ovarian cancer
HK1238718A1 (en) Prostate cancer gene profiles and methods of using the same
WO2021178832A2 (en) Dna damage repair genes in cancer
CA2934878C (en) Genomic rearrangements associated with prostate cancer and methods of using the same
EP2607494A1 (en) Biomarkers for lung cancer risk assessment
HK1238683A1 (en) Genomic rearrangements associated with prostate cancer and methods of using the same
EP2814982A1 (en) New method for prognosing the survival of patients suffering from chronic myelomonocytic leukaemia

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20191029

EEER Examination request

Effective date: 20191029

EEER Examination request

Effective date: 20191029

FZDE Discontinued

Effective date: 20240206